To determine early predictors of abnormal outcome at Z24 months' age in neonates at risk for hypoxic-ischemic brain injury.
INTRODUCTION
Predicting neonatal and infant morbidity after perinatal hypoxicischemic injury has been difficult. 1 Despite dramatic improvement in perinatal care over the last few decades, morbidity secondary to hypoxic-ischemic injury to the neonatal brain still remains a significant problem. 2, 3 Several new modalities of therapy are suggested to decrease brain injury after perinatal hypoxia. [4] [5] [6] [7] Clinicians have deferred delivery of these therapies due to lack of markers that would identify infants at high risk for an abnormal neurologic outcome. Several reports indicate that clinical indicators of fetal asphyxia individually do not predict neonatal or long-term morbidity. Individually, umbilical cord blood acidemia, [8] [9] [10] [11] Apgar scores at 1 and 5 minutes, 12, 13 fetal monitoring 14 and neonatal seizures 15 have not shown any significant correlation with longterm neurologic morbidity. Various biochemical markers like nucleated RBCs, 16 cord erythropoetin 17 and serum creatinine phosphokinase with isoenzymes 18 have been evaluated but were found to have a low specificity or they become clinically evident at a time too late for any intervention. Advanced techniques like amplitude-integrated electroencephalogram recordings, 19 visualevoked potentials and sensory-evoked potentials 20 have been found to have a good predictive value but are not routinely available. A recent prospective evaluation of a scoring system 21, 22 has shown good predictive value for immediate neonatal morbidity.
Experimental evidence from animal studies suggests neuroprotective strategies should be initiated early within first 6 hours after birth and prior to onset of seizures. 23, 24 Most of the studies done so far using clinical and biochemical parameters lack adequate follow-up or have used markers not routinely available during the first few hours of life. We therefore initiated a study to prospectively evaluate infants at high risk for neurologic morbidity because of fetal asphyxia. It was our hypothesis that a combination of perinatal risk factors, both physiological and biochemical, available within the first hour after birth, would predict death and/ or neurologic sequelae following perinatal asphyxia.
METHODS
The protocol was reviewed and approved by the Institutional Review Board at The University of Tennessee Health Science Center. All the neonates admitted to the newborn nursery were screened for the study. Infants were enrolled if they were admitted to the NICU within the first 12 hours of life, Z35 weeks' gestational age, and if they met three of the following five conditions suggesting perinatal hypoxic-ischemic insult: (1) Apgar scores at 1 minute r3 or 5 minutes r5; (2) pH <7.1 or base deficit (BD) >10 mmol/l from cord arterial blood or from blood gas determination within 1 hour after birth in the NICU or at the referring hospital, if outborn; (3) abnormal fetal monitoring, indicated by prolonged fetal bradycardia (>90 seconds), variable or late decelerations, abnormal nonstress test and/or biophysical profile <6; (4) highrisk obstetrical history (placenta previa or abruptio, bleeding, dystocia, severe toxemia, meconium-stained amniotic fluid); (5) evidence of neonatal neurologic dysfunction after birth for the first 12 hours (hypotonia, hypertonia, coma, seizures). To avoid exclusion of babies with moderate asphyxia who may or may not have had severe acidemia or multiorgan dysfunction, we did not include all the criteria of birth asphyxia proposed by the American College of Obstetricians and Gynecologists (ACOG). 25 Furthermore, multiorgan failure and abnormal neurologic findings or hypoxic-ischemic encephalopathy (HIE) may not be evident early in the neonatal course. Exclusion criteria included infants <36 weeks' gestational age, major congenital anomalies and/or in utero infections.
A prospective data collection from detailed postnatal history and laboratory data for the first 7 days after birth was carried out. Delivery room (DR) management and labor and delivery data were reviewed and recorded in detail, including drugs administered. Clinical examination was done by the attending physician, and management of the neonate was at his/her discretion. Laboratory data included hematocrit, WBC count with a differential, nucleated RBC count, platelet count and reticulocyte count at birth, 12 to 24, 72 hours and 7 days after birth. Blood urea nitrogen and plasma creatinine were also recorded for the same time period. Urine output at 12, 24 and 72 hours was recorded. Admission plasma sodium, glucose, calcium and magnesium were recorded along with maximum and minimum levels in the first 7 days after birth. Liver function tests and creatinine phosphokinase with isoenzymes were recorded at 24 and 72 hours after birth. Maximum and minimum PCO 2 in the first 24 hours were also recorded. Results of imaging studies and brainstem auditory evoked responses during hospital stay were also documented if available. Imaging studies were considered abnormal if cranial ultrasound, head computerized tomography scans or head magnetic resonance imaging (MRI) showed evidence of intracranial hemorrhage or infarct at any time after birth during the hospital stay. Severity of neonatal encephalopathy was determined according to Sarnat's classification 26 for HIE in neonates. Multiorgan involvement was defined as two or more organ system dysfunctions after birth. Organ systems assessed included: cardiac, pulmonary, neurologic, gastrointestinal, hepatic, hematologic and renal systems. Cardiovascular dysfunction was defined as the need for vasopressors to maintain adequate blood pressure and/or echocardiographic evidence of left ventricular dysfunction. Pulmonary involvement indicated evidence of pulmonary hypertension, as assessed clinically or by echocardiography. Neurologic abnormalities were determined based on the presence of HIE from Sarnat's classification, seizures or intracranial hemorrhage. Necrotizing enterocolitis, gastric hemorrhage and intestinal perforations were categorized under gastrointestinal complications. Elevated liver enzymes comprised the criteria of liver involvement. Hematologic complications included disseminated intravascular coagulopathy and thrombocytopenia. Renal insufficiency was defined as a urine output <1 cm 3 /kg h and plasma creatinine level >1.3 mg/dl. At discharge, all infants were assessed for neurological abnormalities, including abnormal tone, reflexes or posture. Postdischarge infants were assessed at intervals (1, 4, 8, 12 18, 24 and 30 months' corrected age) at the developmental follow-up clinic. Assessments during these visits included interval medical history and physical and neurological examination. In addition at Z18 months' corrected age, the developmental assessment was carried out using the Bayley Scales of Infant Development II by a clinical psychologist not aware of the clinical findings at birth. An abnormal outcome was defined as death, abnormal neurological findings such as cerebral palsy, subnormal Bayley scores (MDI <70, PDI <70), or a subnormal motor quotient (MQ) <70.
27,28
Statistical Analysis Data were expressed as means, medians or proportions. t-Test or Wilcoxson rank sum test was used for univariate analysis. Categorical or nominal variables were compared using Fisher's exact test. A P-value of <0.05 was decided arbitrarily for statistical significance. Multivariate analysis was performed to create models that would predict outcome at Z24 months of age. One model used variables within 24 hours after birth with P<0.1 by univariate analysis, while the second used all the variables with P<0.1 from birth until hospital discharge. Further, using variables significant at P<0.05 by univariate analysis and evident within the first hour after birth, a scoring system was devised. A classification tree model 29 was used to select significant factors and to determine the categories within each variable. The scoring system was examined for its sensitivity and specificity to predict the neurologic outcome at Z24 months of age in the patients enrolled.
RESULTS
Of the total of 9064 live-born infants delivered at the Regional Medical Center between January 1996 and June 1998, and 196 outborn admitted to the hospital, 41 infants were enrolled in the study based on the criteria. Four (8%) infants were transferred from outlying hospitals. At discharge, 15 infants (including four deaths) had abnormal neurological examination. In total, 39 (95%) infants had known outcome at 24 months of age. Two infants were lost on follow-up. The mean age at follow-up was 32 months' corrected age (28 to 36 months). A total of five deaths occurred, four during hospital stay and one death at 9 months related to complications of asphyxia. In total, 22 infants had normal outcome while17 had abnormal outcome; that is, five deaths or MQ <70 indicating more than 30% delay in development. The MQ <70 correlated with either MDI or PDI being <70. Of the survivors, 11 had CP (including global retardation, spastic CP, hemiplegic CP), while four had developmental delay more than 30%. The mean birth weight and gestational age of those with normal outcomes were 3077 g and 38.5 weeks, respectively, comparable to those with abnormal outcomes who had mean birth weight of 3029 g and gestational age of 37.7 weeks. In all, 27 and 40%, respectively, of those with normal and abnormal outcomes were males. As to other factors, the following were noted between those with normal and abnormal outcomes: Cesarean section deliveries (60 vs 75%), meconium-stained amniotic fluid (33 vs 25%), abruptio placentae in (18 vs 41%, P ¼ 0.11), cocaine exposure (12.5 vs 10%), and smoking (12.5 vs 20%). The median 1-and 5-minute Apgar scores in those with normal outcomes were 3 and 5, respectively, compared to the median scores of 1 and 3 in those with abnormal outcomes. In total, 68% of those who were normal required intubation in the delivery room compared to 100% of those with abnormal outcomes, P ¼ 0.01. Among those with normal outcome, 75% had initial or cord pH of r7.00 compared to 65% (P<0.50) in those abnormal. Initial or cord BD Z20 mmol/l were noted in 20 and 70%, respectively, of those with normal and abnormal outcomes. Thus, variables within the first hour of life, which were significantly different, were 1-and 5-minute Apgar scores (P ¼ 0.01 and 0.005 respectively), BD of Z20 mmol/l on cord/initial blood gas measurement (P ¼ 0.001), resuscitation with intubation for positive pressure ventilation (P ¼ 0.01).
Of all the predictor variables evident during the hospital stay, nucleated RBCs, elevated plasma creatinine or decreased urine output did not differ between the infants with normal and abnormal outcomes; however, outcome was significantly related to seizures and an abnormal imaging study (Table 1) . Abnormal findings on imaging studies (either ultrasound, CT scan or MRI) included cerebral edema, ischemic changes in periventricular, thalamic or globus pallidus or hemorrhage in the frontal, parietal or diffuse cerebral areas. Pulmonary hypertension and cardiac dysfunction were significant in predicting abnormal outcome while renal and hepatic dysfunctions were not. Intestinal perforation occurred in one patient only. Seizures were noted in 61.5% (24/39) infants. Two infants with abnormal outcome had seizures noted within 1 h after birth; another eight had seizures by 6 hours of age, and an additional five by 12 hours of age. Of those with normal outcome, none was noted with seizures in the first hour of life, five had seizures by 6 hours of age and another four by 12 hours of age. Seizures were significantly related with 1-and 5-minute Apgar score (P ¼ 0.002 and 0.001 respectively), low cord pH (P ¼ 0.01) and resuscitation with intubation in the DR (P ¼ 0.003). Table 2 shows the results of the stepwise logistic regression model to predict outcome using variables during the first 24 hours of life that were significant at P<0.1 by univariate analysis. A combination of seizures and BD>17 mmol/l was highly predictive of abnormal outcome. Table 2 also shows the results of stepwise logistic regression using factors from birth until hospital discharge. Only 5-minute Apgar r3 and abnormal imaging studies were retained in the model predictive of abnormal outcome. Since the two previous models were based on variables either observed in the first 24 hours of life or observed till discharge, we determined if early factors within the first hour of life may also be used to predict long-term outcomes. We therefore devised a scoring system using the significant early factors to predict outcome. The Apgar score at 5 minutes, cord/initial BD, and resuscitation in the DR were selected in the model, and the categories derived are shown in Table 3 . Thus, from the devised scoring system, a score Z4 was highly predictive of abnormal outcome at Z24 months of age. This score had a PPV 75% (n ¼ 41) ( Table 4 ). The PPV improved to 90% with the score of Z5.
We applied the scoring system devised by Portman et al. 21, 22 to our subjects. Their scoring system predicted outcome at discharge (P ¼ 0.006) but not the outcome at Z24 months of age (P ¼ 0.08) ( Table 4) . Patients enrolled in our study were retrospectively reclassified according to the ACOG definition 25 of perinatal asphyxia, and correlation with long-term outcome was established according to this definition. Of the 41 infants with known outcome, 12 met all the criteria for this definition. Nine of 12 had abnormal outcome, and three had normal outcome (P ¼ 0.015) at Z24 months of age.
DISCUSSION
Various clinical studies have reported multiple factors predicting outcome of infants after perinatal asphyxia. Few of these studies have followed infants to at least 1 year of age. 14,30 -32 We followed infants at high risk of hypoxic brain injury until Z24 months and found a combination of early neonatal factors that could predict a high incidence of neurologic deficit later in life. Since we wanted to establish and evaluate potential selection criteria for experimental therapies, included in the population were infants who we determined to be at a moderate-to-high risk of developing longterm neurologic sequelae attributable to perinatal hypoxicischemic injury. However, these criteria for selection of our cohort should not be applied to determine the true incidence of perinatal asphyxia. Our criteria may also be so strict that a number of infants may have had perinatal HIE but did not meet our defined criteria and therefore were not included in the study; these criteria, however, were not too stringent since a number of infants were normal at 24 months of age. A control population was not studied as all entry parameters were not available in healthy term infants.
Along with acute neonatal encephalopathy, multiorgan dysfunction associated with asphyxia 31, 33, 34 in the neonatal period includes renal failure, 35 respiratory depression or distress, hepatic damage, myocardial dysfunction, necrotizing enterocolitis and disseminated intravascular coagulopathy. The incidence of acute system involvement in our cohort was similar to that described by Martin-Ancel et al., 33 who reported one or more organ involvement, renal insufficiency, cardiac dysfunction, and pulmonary dysfunction in 82, 42, 29 and 26% infants, respectively. In our cohort, 85, 50, 29 and 34% infants, respectively, had one or more organ involvement, renal dysfunction, cardiac dysfunction and pulmonary dysfunction. The gastrointestinal tract involvement incidence differed markedly from that reported in the study by Martin-Ancel et al., possibly because of the difference in defining gastrointestinal involvement. Our cohort appears to be characteristic of a large population of asphyxiated infants.
Perlman and Risser 36 have shown a high correlation of 5-minute Apgar r5, cord pH r7.00 and intubation in the DR for resuscitation with the occurrence of seizure in the neonatal period. We also found in our cohort that 5-minute Apgar score, cord pH and intubation for resuscitation in the DR were highly predictive of seizures in the neonatal period. Furthermore, when values of 5-minute Apgar score and intubation for resuscitation in the DR along with cord/initial BD were categorized for a scoring system, the scores identified a large proportion of infants at high risk for later abnormal outcome. In their study, Carter et al. 22 validated a scoring system derived from perinatal variables recorded in the first hour of life to predict neonatal morbidity, but they did not follow their patients longer than the newborn period. We applied their scoring system to our population and found that their scoring system predicted abnormal outcome at discharge quite well, but did not significantly predict abnormal outcome at later age. However, since our patients were retrospectively scored, it would be unwise to reject their scoring system without trying a prospective validation for outcome longer than published in their studies.
In a retrospective analysis, Ekert et al. 32 used onset of breathing, chest compressions and onset of seizures within 4 hours as variables to form a model for prediction of abnormal outcome at 1 year of age. A limitation of their study is its retrospective data collection and subjects were primarily outborn (92%). Also, the variable, timing of onset of breathing, is not routinely recorded on the delivery chart and hence not always available. The exclusion of the deaths prior to referral to their institute may exclude some abnormal patients who can be potentially selected for intervention. In our study population, of the many individual factors in the first 24 hours of life that were significantly related to the outcome, only 5-minute Apgar score and seizures were retained in the stepwise logistic regression model. Several of our patients had seizures with onset after 4 hours of age; seizures may already indicate existing brain injury and thus may not be an optimal variable for selecting candidates for neuroprotective therapies.
As reported by Barkovich et al., 37 abnormalities on MRI studies predicted poor neuromotor outcome. We also found that abnormal imaging studies in combination with a 5-minute Apgar score r3 were significantly related to abnormal outcome. Inability to obtain a neuroimaging study easily within the first few hours of life precludes use of imaging as a screening for infants that may be chosen for experimental neuroprotective therapy. Also, our patients did not uniformly have one study but had a combination of ultrasound, CT scan and MRI and thus we were unable to evaluate each type of imaging modality individually as a reliable predictor of long-term outcome.
Our scoring system is as sensitive as the criteria put forward by the 1992 ACOG Task Force, 25 in predicting both neonatal morbidity and outcome at 24 months. The diagnosis by these criteria would require multiorgan failure which may be delayed for up to 72 hours after birth. We followed our infants until at least 24 months' corrected age; this duration for follow-up may not be adequate. However, Shankaran et al. 31 have shown that neurologic examination at 1 year is very sensitive (93.5%) in predicting the neurologic status at 5 years of age in term asphyxiated infants.
The criteria to define an acute intrapartum event sufficient to cause cerebral palsy have been modified by the ACOG Task Force 38, 39 recently. This requires the presence of cerebral palsy of spastic or dyskinetic type and exclusion of certain conditions along with other criteria. With the revised task force criteria, establishing the association between intrapartum HIE and subsequent cerebral palsy would be made at later age when spastic or dyskinetic type of cerebral palsy becomes evident. Although the risk factors in our study had a high predictive value for abnormal outcome, the presence of these risk factors should not be construed as diagnostic of cerebral palsy with intrapartum origin. Rather, the early factors such as in our proposed scoring system may be helpful in identification of patients who are at risk for abnormal outcomes and therefore may benefit from neuroprotection strategies. The proposed scoring system uses simple, objective parameters and would minimize variation among different centers if there were to be a multisite trial. As this could be used as early as 60 minutes of life, it may be an appropriate tool to select patients for experimental therapy for hypoxic brain injury. A prospective validation of this scoring system may be required prior to its routine use.
